Efficacy of the combination of venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

被引：225
作者：
Aldoss, Ibrahim [1 ]
Yang, Dongyun [2 ]
Aribi, Ahmed [1 ]
Ali, Haris [1 ]
Sandhu, Karamjeet [1 ]
Al Malki, Monzr M. [1 ]
Mei, Matthew [1 ]
Salhotra, Amandeep [1 ]
Khaled, Samer [1 ]
Nakamura, Ryotaro [1 ]
Snyder, David [1 ]
O'Donnell, Margaret [1 ]
Stein, Anthony S. [1 ]
Forman, Stephen J. [1 ]
Marcucci, Guido [1 ]
Pullarkat, Vinod [1 ]
机构：
[1] City Hope Natl Med Ctr, Gehr Family Ctr Leukemia Res, Dept Hematol & Hematopoiet Cell Transplant, Duarte, CA 91010 USA
[2] City Hope Natl Med Ctr, Dept Informat Sci, Div Biostat, Duarte, CA USA
来源：
HAEMATOLOGICA | 2018年 / 103卷 / 09期
关键词：
CONVENTIONAL CARE REGIMENS; OLDER PATIENTS; AZACITIDINE; AML; RECOMMENDATIONS; DIAGNOSIS; TARGETS;
D O I：
10.3324/haematol.2018.188094
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E404 / E407
页数：4
相关论文
共 12 条
  • [1] [Anonymous], 2017, BLOOD S1
  • [2] BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies
    Bogenberger, J. M.
    Kornblau, S. M.
    Pierceall, W. E.
    Lena, R.
    Chow, D.
    Shi, C-X
    Mantei, J.
    Ahmann, G.
    Gonzales, I. M.
    Choudhary, A.
    Valdez, R.
    Camoriano, J.
    Fauble, V.
    Tiedemann, R. E.
    Qiu, Y. H.
    Coombes, K. R.
    Cardone, M.
    Braggio, E.
    Yin, H.
    Azorsa, D. O.
    Mesa, R. A.
    Stewart, A. K.
    Tibes, R.
    [J]. LEUKEMIA, 2014, 28 (08) : 1657 - 1665
  • [3] Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
    Cheson, BD
    Bennett, JM
    Kopecky, KJ
    Büchner, T
    Willman, CL
    Estey, EH
    Schiffer, CA
    Döhner, H
    Tallman, MS
    Lister, TA
    LoCocco, F
    Willemze, R
    Biondi, A
    Hiddemann, W
    Larson, RA
    Löwenberg, B
    Sanz, MA
    Head, DR
    Ohno, R
    Bloomfield, CD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) : 4642 - 4649
  • [4] Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
    Doehner, Hartmut
    Estey, Elihu
    Grimwade, David
    Amadori, Sergio
    Appelbaum, Frederick R.
    Buechner, Thomas
    Dombret, Herve
    Ebert, Benjamin L.
    Fenaux, Pierre
    Larson, Richard A.
    Levine, Ross L.
    Lo-Coco, Francesco
    Naoe, Tomoki
    Niederwieser, Dietger
    Ossenkoppele, Gert J.
    Sanz, Miguel
    Sierra, Jorge
    Tallman, Martin S.
    Tien, Hwei-Fang
    Wei, Andrew H.
    Lowenberg, Bob
    Bloomfield, Clara D.
    [J]. BLOOD, 2017, 129 (04) : 424 - 447
  • [5] International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
    Dombret, Herve
    Seymour, John F.
    Butrym, Aleksandra
    Wierzbowska, Agnieszka
    Selleslag, Dominik
    Jang, Jun Ho
    Kumar, Rajat
    Cavenagh, James
    Schuh, Andre C.
    Candoni, Anna
    Recher, Christian
    Sandhu, Irwindeep
    Bernal del Castillo, Teresa
    Al-Ali, Haifa Kathrin
    Martinelli, Giovanni
    Falantes, Jose
    Noppeney, Richard
    Stone, Richard M.
    Minden, Mark D.
    McIntyre, Heidi
    Songer, Steve
    Lucy, Lela M.
    Beach, C. L.
    Doehner, Hartmut
    [J]. BLOOD, 2015, 126 (03) : 291 - 299
  • [6] Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
    Fenaux, Pierre
    Mufti, Ghulam J.
    Hellstrom-Lindberg, Eva
    Santini, Valeria
    Gattermann, Norbert
    Germing, Ulrich
    Sanz, Guillermo
    List, Alan F.
    Gore, Steven
    Seymour, John F.
    Dombret, Herve
    Backstrom, Jay
    Zimmerman, Linda
    McKenzie, David
    Beach, C. L.
    Silverman, Lewis R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) : 562 - 569
  • [7] Azacitidine for the treatment of relapsed and refractory AML in older patients
    Itzykson, Raphael
    Thepot, Sylvain
    Berthon, Celine
    Delaunay, Jacques
    Bouscary, Didier
    Cluzeau, Thomas
    Turlure, Pascal
    Prebet, Thomas
    Dartigeas, Caroline
    Marolleau, Jean-Pierre
    Recher, Christian
    Plantier, Isabelle
    Stamatoullas, Aspasia
    Devidas, Alain
    Taksin, Anne-Laure
    Guieze, Romain
    Caillot, Denis
    Vey, Norbert
    Ades, Lionel
    Ifrah, Norbert
    Dombret, Herve
    Fenaux, Pierre
    Gardin, Claude
    [J]. LEUKEMIA RESEARCH, 2015, 39 (02) : 124 - 130
  • [8] Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
    Konopleva, Marina
    Pollyea, Daniel A.
    Potluri, Jalaja
    Chyla, Brenda
    Hogdal, Leah
    Busman, Todd
    McKeegan, Evelyn
    Salem, Ahmed Hamed
    Zhu, Ming
    Ricker, Justin L.
    Blum, William
    DiNardo, Courtney D.
    Kadia, Tapan
    Dunbar, Martin
    Kirby, Rachel
    Falotico, Nancy
    Leverson, Joel
    Humerickhouse, Rod
    Mabry, Mack
    Stone, Richard
    Kantarjian, Hagop
    Letai, Anthony
    [J]. CANCER DISCOVERY, 2016, 6 (10) : 1106 - 1117
  • [9] Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma
    Kumar, Shaji
    Kaufman, Jonathan L.
    Gasparetto, Cristina
    Mikhael, Joseph
    Vij, Ravi
    Pegourie, Brigitte
    Benboubker, Lofti
    Facon, Thierry
    Amiot, Martine
    Moreau, Philippe
    Punnoose, Elizabeth A.
    Alzate, Stefanie
    Dunbar, Martin
    Xu, Tu
    Agarwal, Suresh K.
    Enschede, Sari Heitner
    Leverson, Joel D.
    Ross, Jeremy A.
    Maciag, Paulo C.
    Verdugo, Maria
    Touzeau, Cyrille
    [J]. BLOOD, 2017, 130 (22) : 2401 - 2409
  • [10] BCL-2 Inhibition Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cells
    Lagadinou, Eleni D.
    Sach, Alexander
    Callahan, Kevin
    Rossi, Randall M.
    Neering, Sarah J.
    Minhajuddin, Mohammad
    Ashton, John M.
    Pei, Shanshan
    Grose, Valerie
    O'Dwyer, Kristen M.
    Liesveld, Jane L.
    Brookes, Paul S.
    Becker, Michael W.
    Jordan, Craig T.
    [J]. CELL STEM CELL, 2013, 12 (03) : 329 - 341
12